Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

289 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Identification and manipulation of tumor associated macrophages in human cancers.
Heusinkveld M, van der Burg SH. Heusinkveld M, et al. Among authors: van der burg sh. J Transl Med. 2011 Dec 16;9:216. doi: 10.1186/1479-5876-9-216. J Transl Med. 2011. PMID: 22176642 Free PMC article. Review.
Cytotoxic T lymphocytes raised against a subdominant epitope offered as a synthetic peptide eradicate human papillomavirus type 16-induced tumors.
Feltkamp MC, Vreugdenhil GR, Vierboom MP, Ras E, van der Burg SH, ter Schegget J, Melief CJ, Kast WM. Feltkamp MC, et al. Among authors: van der burg sh. Eur J Immunol. 1995 Sep;25(9):2638-42. doi: 10.1002/eji.1830250935. Eur J Immunol. 1995. PMID: 7589138
Antibodies against p53 are associated with poor prognosis of colorectal cancer.
Houbiers JG, van der Burg SH, van de Watering LM, Tollenaar RA, Brand A, van de Velde CJ, Melief CJ. Houbiers JG, et al. Among authors: van der burg sh, van de watering lm, van de velde cj. Br J Cancer. 1995 Sep;72(3):637-41. doi: 10.1038/bjc.1995.386. Br J Cancer. 1995. PMID: 7669574 Free PMC article.
p53, a potential target for tumor-directed T cells.
Nijman HW, Van der Burg SH, Vierboom MP, Houbiers JG, Kast WM, Melief CJ. Nijman HW, et al. Among authors: van der burg sh. Immunol Lett. 1994 May;40(2):171-8. doi: 10.1016/0165-2478(94)90189-9. Immunol Lett. 1994. PMID: 8088874
Identification of HLA-A*0201-restricted CTL epitopes encoded by the tumor-specific MAGE-2 gene product.
Visseren MJ, van der Burg SH, van der Voort EI, Brandt RM, Schrier PI, van der Bruggen P, Boon T, Melief CJ, Kast WM. Visseren MJ, et al. Among authors: van der burg sh, van der voort ei, van der bruggen p. Int J Cancer. 1997 Sep 26;73(1):125-30. doi: 10.1002/(sici)1097-0215(19970926)73:1<125::aid-ijc19>3.0.co;2-f. Int J Cancer. 1997. PMID: 9334819
Strategies for immunotherapy of cancer.
Melief CJ, Toes RE, Medema JP, van der Burg SH, Ossendorp F, Offringa R. Melief CJ, et al. Among authors: van der burg sh. Adv Immunol. 2000;75:235-82. doi: 10.1016/s0065-2776(00)75006-1. Adv Immunol. 2000. PMID: 10879286 Review. No abstract available.
p53: a potential target antigen for immunotherapy of cancer.
Offringa R, Vierboom MP, van der Burg SH, Erdile L, Melief CJ. Offringa R, et al. Among authors: van der burg sh. Ann N Y Acad Sci. 2000 Jun;910:223-33; discussion 233-6. doi: 10.1111/j.1749-6632.2000.tb06711.x. Ann N Y Acad Sci. 2000. PMID: 10911916 Review.
Importance of CD4(+) T helper cell responses in tumor immunity.
Ossendorp F, Toes RE, Offringa R, van der Burg SH, Melief CJ. Ossendorp F, et al. Among authors: van der burg sh. Immunol Lett. 2000 Sep 15;74(1):75-9. doi: 10.1016/s0165-2478(00)00252-2. Immunol Lett. 2000. PMID: 10996631 Review. No abstract available.
Natural T-helper immunity against human papillomavirus type 16 (HPV16) E7-derived peptide epitopes in patients with HPV16-positive cervical lesions: identification of 3 human leukocyte antigen class II-restricted epitopes.
van der Burg SH, Ressing ME, Kwappenberg KM, de Jong A, Straathof K, de Jong J, Geluk A, van Meijgaarden KE, Franken KL, Ottenhoff TH, Fleuren GJ, Kenter G, Melief CJ, Offringa R. van der Burg SH, et al. Among authors: van meijgaarden ke. Int J Cancer. 2001 Mar 1;91(5):612-8. doi: 10.1002/1097-0215(200002)9999:9999<::aid-ijc1119>3.0.co;2-c. Int J Cancer. 2001. PMID: 11267969
Induction of p53-specific immune responses in colorectal cancer patients receiving a recombinant ALVAC-p53 candidate vaccine.
van der Burg SH, Menon AG, Redeker A, Bonnet MC, Drijfhout JW, Tollenaar RA, van de Velde CJ, Moingeon P, Kuppen PJ, Offringa R, Melief CJ. van der Burg SH, et al. Among authors: van de velde cj. Clin Cancer Res. 2002 May;8(5):1019-27. Clin Cancer Res. 2002. PMID: 12006514 Clinical Trial.
289 results
Jump to page
Feedback